Vilin Bio Med Limited (NSE:VILINBIO)

Vilin Bio Med Revenue

In the fiscal year ending March 31, 2026, Vilin Bio Med had annual revenue of 422.63M INR with 185.37% growth. Vilin Bio Med had revenue of 325.99M in the half year ending March 31, 2026, with 289.22% growth.

• Revenue: 422.63M
• Revenue Growth: +185.37%
• P/S Ratio: 1.53
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 648.68M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	422.63M	274.53M	185.37%
Mar 31, 2025	148.10M	-9.95M	-6.30%
Mar 31, 2024	158.05M	34.68M	28.11%
Mar 31, 2023	123.37M	11.18M	9.97%
Mar 31, 2022	112.19M	-5.00M	-4.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 11, 2026

Data Sources Report a data error